Functional drug susceptibility testing using single-cell mass predicts treatment outcome in patient-derived cancer neurosphere models

Summary: Functional precision medicine aims to match individual cancer patients to optimal treatment through ex vivo drug susceptibility testing on patient-derived cells. However, few functional diagnostic assays have been validated against patient outcomes at scale because of limitations of such as...

Full description

Bibliographic Details

Published in:	Cell Reports
Main Authors:	Max A. Stockslager, Seth Malinowski, Mehdi Touat, Jennifer C. Yoon, Jack Geduldig, Mahnoor Mirza, Annette S. Kim, Patrick Y. Wen, Kin-Hoe Chow, Keith L. Ligon, Scott R. Manalis
Format:	Article
Language:	English
Published:	Elsevier 2021-10-01
Subjects:	functional drug susceptibility testing glioblastoma cancer cell mass cell size
Online Access:	http://www.sciencedirect.com/science/article/pii/S221112472101247X